Authors: Shigekiyo Matsumoto Seigou Hidaka Koji Goto Satoshi Hagiwara Chihiro Shingu Hideo Iwasaka Takayuki Noguchi
Publish Date: 2009/05/15
Volume: 23, Issue: 2, Pages: 288-291
Abstract
Resuscitation and acute cerebral damage after cardiopulmonary arrest often induce a systemic inflammatory response and subsequently cause multiple organ failure including acute lung injury ALI Sivelestat has been reported to be effective for ALI associated with systemic inflammatory response syndrome SIRS but the effectiveness and safety of the drug for infants has not been confirmed We report a 33dayold infant who developed acute respiratory distress syndrome ARDS following hypoxic encephalopathy immediately after successful resuscitation from cardiopulmonary arrest Sivelestat was administered continuously for 7 days with no adverse reactions and consolidations on a chest radiograph were diminished and impaired oxygenation was markedly alleviated Our experience suggests that intravenous sivelestat offers a new therapeutic strategy for infantile ARDS/ALI but further investigation of the indication administration period and dosage is required
Keywords: